Brief: Outlook Therapeutics - Terminates May 13, 2026 Prospectus Supplement For ATM Offering Agreement With H.C. Wainwright
12/08/2026 22:16
BRIEF-Outlook Therapeutics - Terminates May 13, 2026 Prospectus Supplement For ATM Offering Agreement With H.C. Wainwright Aug 12 (Reuters) - Outlook Therapeutics Inc OTLK.O:
OUTLOOK THERAPEUTICS - TERMINATES MAY 13, 2026 PROSPECTUS SUPPLEMENT FOR ATM OFFERING AGREEMENT WITH H.C. WAINWRIGHT - SEC FILING
Further company coverage: OTLK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce